Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inogen (INGN) Gains from Investment Securities (2016 - 2022)

Inogen (INGN) has disclosed Gains from Investment Securities for 11 consecutive years, with $1.5 million as the latest value for Q4 2022.

  • On a quarterly basis, Gains from Investment Securities fell 85.08% to $1.5 million in Q4 2022 year-over-year; TTM through Dec 2022 was $9.4 million, a 14310.77% increase, with the full-year FY2025 number at $821000.0, up 397.58% from a year prior.
  • Gains from Investment Securities was $1.5 million for Q4 2022 at Inogen, up from $383537.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $16.1 million in Q1 2018 to a low of -$14.5 million in Q2 2018.
  • A 5-year average of -$83935.0 and a median of $37161.0 in 2019 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: soared 30037.47% in 2018, then crashed 28313.64% in 2019.
  • Inogen's Gains from Investment Securities stood at $22000.0 in 2018, then plummeted by 28313.64% to -$6.2 million in 2019, then soared by 108.31% to $516000.0 in 2020, then surged by 1816.09% to $9.9 million in 2021, then tumbled by 85.08% to $1.5 million in 2022.
  • Per Business Quant, the three most recent readings for INGN's Gains from Investment Securities are $1.5 million (Q4 2022), $383537.0 (Q3 2022), and $388537.0 (Q2 2022).